// Latest Publications:
205. Design, rationale, and baseline characteristics of the dapagliflozin in haemodialysis (DAPA-HD) trial. ESC Heart Fail 2026, 13(3):xvag104. (IF 3.7)
Zelniker TA, Paschen C, Mann C, Eigner M, Hafner-Gießauf H, Kletzmayr J, Lorenz M, Ludvik B, Stulnig T, Waller I, Werzowa J, Hödlmoser S, Hengstenberg C, Oberbauer R, Hecking M.
204. Donor-reactive clonotypes are overrepresented in the urinary T-cell repertoire during kidney transplant rejection and show distinct dynamics in the circulation. Am J Transplant 2026 (in press)
Aschauer C, Heinzel A, Hu K, Chen HS, Reindl-Schwaighofer R, Wekerle T, Sykes M, David AF, Oberbauer R.
203. Visceral Adipose Tissue Alters Podometrics and Renal Compensation After Uninephrectomy. Kidney Int Rep. 2025, 11(3):103739.
Paschen C, Koeller MC, Hennenberg J, Kläger J, Nackenhorst M, Oszwald A, Kammer M, Kozakowski N, Tamandl D, Regele H, Oberbauer R.